Researchers from The Univ. of Texas at Dallas and the Univ. of Tokyo have created electronic devices that become soft when implanted inside the body and can deploy to grip 3-D objects, such as large tissues, nerves and blood vessels. These biologically adaptive, flexible transistors might one day help doctors learn more about what is happening inside the body, and stimulate the body for treatments.
It looks like a game board and many of its users will find it fun, but there’s serious intent behind a device by Rice Univ. students to test the abilities of cerebral palsy patients. At the heart of the DeXcellence platform is a small peg comfortable enough for a three-year-old to hold. But packed inside are enough electronics to tell a nearby computer, tablet or other Bluetooth-enabled device of how the cylinder is moving in space.
Welcome to the virtual house call, the latest twist on telemedicine. It's increasingly getting attention as a way to conveniently diagnose simple maladies, such as whether that runny nose and cough is a cold or the flu. One company even offers a smartphone app that connects to a doctor. Patient groups and technology advocates are now pushing to expand this approach digital care to people with complex chronic diseases.
When you get sick, your physician may take a sample of your blood, send it to the laboratory and wait for results. In the near future, however, doctors may be able to run those tests almost instantly on a piece of plastic about the size of credit card. These labs-on-a-chip would not only be quick—results are available in minutes—but also inexpensive and portable.
When someone suffers from a stroke, a silent countdown begins. A fast diagnosis and treatment can mean the difference between life and death. So scientists are working on a new blood test that one day could rapidly confirm whether someone is having a stroke and what kind.
Researchers have recently developed a unique technology to help physicians perform ultrasound-guided procedures involving needle placement. The new imaging technology, created by Clear Guide Medical, allows physicians to plan needle entry and a precise line to the target before the needle ever enters the patient’s organ or tissue. The result is more efficient, less damaging, and less stressful needle-placement procedures for patients.
In medicine, time isn't just money: it can mean the difference between life and death. Clot-busters must be given in the first hour of arrival in a hectic emergency room. Intravenous medications can spoil, and catheters that overstay their welcome invite infection.
An interdisciplinary team of scientists in Belgium has developed a new technique to examine how proteins interact with each other at the level of a single HIV viral particle. The technique allows scientists to study the life-threatening virus in detail and makes screening potential anti-HIV drugs quicker and more efficient. The technique can also be used to study other diseases.
Launched in 2013, the national BRAIN Initiative aims to revolutionize our understanding of cognition by mapping the activity of every neuron in the human brain, revealing how brain circuits interact to create memories, learn new skills and interpret the world around us. Before that can happen, neuroscientists need new tools that will let them probe the brain more deeply and in greater detail.
Researchers in New York have been able to, for the first time, generate fully functional human cartilage from mesenchymal stem cells by mimicking, in vitro, the developmental process of mesenchymal condensation. While there has been great success in engineering pieces of cartilage using young animal cells, no one has, until now, been able to reproduce these results using adult human stem cells from bone marrow or fat.
In a potential step toward new diabetes treatments, scientists used a cloning technique to make insulin-producing cells with the DNA of a diabetic woman. The approach could someday aid treatment of the Type 1 form of the illness, which is usually diagnosed in childhood and accounts for about 5% of diabetes cases in the U.S.
Using a mixture of cervical cancer cells and a hydrogel substance that resembles an ointment balm, Drexel Univ.’s Wei Sun can print out a tumor model that can be used for studying their growth and response to treatment. This living model will give cancer researchers a better look at how tumors behave and a more accurate measure of how they respond to treatment.
Federal health regulators have cleared a genetic test from Roche as the first ever U.S.-approved alternative to the Pap smear, the decades-old mainstay of cervical cancer screening. The U.S. Food and Drug Administration approved Swiss-based Roche's cobas HPV test to detect the human Papillomavirus, or HPV, in women 25 and up. HPV causes nearly all cases of cervical cancer.
Researchers have developed an ultrasound device that could help identify arterial plaque that is at high risk of breaking off and causing heart attack or stroke. At issue is the plaque that builds up in arteries as we age. Some types of plaque are deemed “vulnerable,” meaning that they are more likely to detach from the artery wall and cause heart attack or stroke.
Australian researchers are trying a novel way to boost the power of cochlear implants: They used the technology to beam gene therapy into the ears of deaf animals and found the combination improved hearing. The approach reported Wednesday isn't ready for human testing, but it's part of growing research into ways to let users of cochlear implants experience richer, more normal sound.
A team at Purdue Univ. has used gold nanoparticles to target and bind to fragments of genetic material known as BRCA1 messenger RNA splice variants, which can indicate the presence and stage of breast cancer. The number of these synthetic DNA “tails” in a cell can be determined in a living cell by examining the specific signal that light produces when it interacts with the gold nanoparticles.
Diagnosed with a degenerative eye disease as a teenager, Roger Pontz has been almost completely blind for years. Now, thanks to a high-tech procedure that involved the surgical implantation of a "bionic eye," he's regained enough of his eyesight to catch small glimpses of his wife, grandson and cat. The company which made the eye, Second Sight, won an R&D 100 Award in 2009 for its artificial retina device.
In the hands of some Rice Univ. senior engineering students, a fishing rod is more than what it seems. For them, it’s a way to help destroy blood clots that threaten lives. Branding themselves as “Team Evacuator,” five students have been testing a device to break up blood clots that form in the bladders of adult patients and currently have to be removed by suction through a catheter in the urethra.
Physicist Wei Chen at Univ. of Texas at Arlington’s Center for Security Advances Via Applied Nanotechnology was testing a copper-cysteamine complex created in his laboratory when he discovered unexplained decreases in its luminescence, or light emitting power, over a time-lapse exposure to x-rays. Further testing work revealed that the “Cu-Cy” nanoparticles, when combined with x-ray exposure, significantly slowed tumor growth in studies.
A team of scientists, led by physicist Amir Yacoby of Harvard Univ., has developed a magnetic resonance imaging (MRI) system that can produce nanoscale images, and may one day allow researchers to peer into the atomic structure of individual molecules. Though not yet precise enough to capture atomic-scale images of a single molecule, the system already has been used to capture images of single electron spins.
These days, Hugh Herr, an assoc. prof. of media arts and sciences at Massachusetts Institute of Technology, gets about 100 emails daily from people across the world interested in his bionic limbs. Messages pour in from amputees seeking prostheses and from media outlets pursuing interviews. Then there are students looking to join Herr’s research group.
Scientists have solved a decades-old medical mystery, and in the process have found a potentially less toxic way to fight invasive fungal infections, which kill about 1.5 million people a year. The researchers say they now understand the mechanism of action of amphotericin, an antifungal drug that has been in use for more than 50 years even though it is nearly as toxic to human cells as it is to the microbes it attacks.
Picking out a face in the crowd is a complicated task: Your brain has to retrieve the memory of the face you’re seeking, then hold it in place while scanning the crowd, paying special attention to finding a match. A new study reveals how the brain achieves this type of focused attention on faces or other objects.
Univ. of Texas at Arlington and Texas Health Arlington Memorial Hospital are investigating whether bone grown from the body’s own stem cells can replace traditional types of bone grafting. The process, which has been successful in previous lab experiments, uses biodegradable polymer scaffolding material and bone morphogenetic protein, or BMP, which was inserted into the abdomen of mice to attract stem cells that in turn produced bone.
In the fight against “superbugs,” scientists have discovered a class of agents that can make some of the most notorious strains vulnerable to the same antibiotics that they once handily shrugged off. Recently discovered metallopolymers, when paired with the same antibiotics MRSA normally dispatches with ease, helped evade the bacteria’s defensive enzymes and destroyed its protective walls, causing the bacteria to burst.